XM does not provide services to residents of the United States of America.
E
E

Equifax

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Equifax, Microstrategy, Netflix

U.S. RESEARCH ROUNDUP-Equifax, Microstrategy, Netflix Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Equifax, Microstrategy and Netflix, on Tuesday. HIGHLIGHTS * Caseys General Stores Inc CASY.O : Jefferies raises target price to $470 from $450 * Equifax Inc EFX.N : JP Morgan cuts target price to $283 from $304 * Microstrategy Inc MSTR.O : Benchmark raises target price to $450 from $300 * Netflix Inc NFLX.O :
F
N
K
F
E

U.S. Coca-Cola, Nextera Energy Partners, ServiceNow

U.S. RESEARCH ROUNDUP-Coca-Cola, Nextera Energy Partners, ServiceNow Oct 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Coca-Cola, Nextera Energy Partners, and ServiceNow on Thursday. HIGHLIGHTS * Avery Dennison Corp AVY.N : JP Morgan cuts to neutral from overweight * Coca-Cola Co KO.N : JP Morgan cuts target price to $75 from $78 * Nextera Energy Partners LP NEP.N : JP Morgan raises to neutral from underweight *
A
A
A
B
C
D
D
E
E
N
R
C
L
T
E
E
I
S
T
A
A
E
E
G
H
L
R

U.S. Elevance Health, Microsoft, UnitedHealth

U.S. RESEARCH ROUNDUP-Elevance Health, Microsoft, UnitedHealth Oct 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, Microsoft, and UnitedHealth, on Friday. HIGHLIGHTS * Air Products APD.N : JP Morgan raises target price to $350 from $340 * Elevance Health ELV.N : RBC cuts target price to $478 from $585 * Microsoft MSFT.O : Piper Sandler cuts target price to $470 from $485 * Texas Capital Bancshares
A
B
D
H
M
N
A
E
E
E
M
M
S

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Wall Street rose on Thursday, with the S&P 500 and the Dow briefly reaching record highs, as chip stocks surged on TSMC's upbeat forecast and stronger-than-expected monthly retail sales indicated a robust U.S. consumer. .N At 13:36 ET, the Dow Jones Industrial Average .DJI was up 0
A
B
C
E
I
N
N
S
S
S
U
U
U
U
A
E

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.